Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group

被引:10
|
作者
Bond, Marinde J. G. [1 ]
Kuiper, Babette I. [2 ,3 ,24 ]
Bolhuis, Karen [4 ,5 ]
Komurcu, Aysun [6 ]
van Amerongen, Martinus J. [7 ]
Chapelle, Thiery [8 ]
Dejong, Cornelis H. C. [9 ,10 ]
Engelbrecht, Marc R. W. [11 ]
Gerhards, Michael F. [12 ]
Grunhagen, Dirk J. [13 ]
van Gulik, Thomas [2 ,3 ]
Hermans, John J. [14 ]
de Jong, Koert P. [15 ]
Klaase, Joost M. [15 ]
Kok, Niels F. M. [16 ]
Leclercq, Wouter K. G. [17 ]
Liem, Mike S. L. [18 ]
van Lienden, Krijn P. [19 ]
Molenaar, I. Quintus [20 ]
Neumann, Ulf P. [9 ,10 ]
Patijn, Gijs A. [21 ]
Rijken, Arjen M. [22 ]
Ruers, Theo M. [16 ]
Verhoef, Cornelis [13 ]
de Wilt, Johannes H. W. [23 ]
Kazemier, Geert [2 ,3 ,24 ]
May, Anne M. [1 ]
Punt, Cornelis J. A. [1 ,4 ]
Swijnenburg, Rutger-Jan [2 ,3 ,24 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands
[2] Univ Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Amsterdam, Netherlands
[4] Amsterdam UMC, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands
[5] Netherlands Canc Inst, Dept Gastrointestinal Oncol, Amsterdam, Netherlands
[6] Netherlands Comprehens Canc Ctr, Utrecht, Netherlands
[7] Sint Maartensklin, Dept Radiol, Nijmegen, Netherlands
[8] Antwerp Univ Hosp, Dept Hepatobiliary Transplantat & Endocrine Surg, Antwerp, Belgium
[9] Maastricht Univ, Dept Surg, Med Ctr, Maastricht, Netherlands
[10] Univ Klinikum Aachen, Aachen, Germany
[11] Amsterdam UMC, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[12] OLVG Hosp, Dept Surg, Amsterdam, Netherlands
[13] Erasmus MC Canc Inst, Dept Surg, Rotterdam, Netherlands
[14] Radboud Univ Nijmegen, Dept Radiol, Med Ctr, Nijmegen, Netherlands
[15] Univ Med Ctr Groningen, Dept Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands
[16] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands
[17] Maxima Med Ctr, Dept Surg, Veldhoven, Netherlands
[18] Med Spectrum Twente, Dept Surg, Enschede, Netherlands
[19] St Antonius Hosp, Dept Radiol, Nieuwegein, Netherlands
[20] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands
[21] Isala Hosp, Dept Surg, Zwolle, Netherlands
[22] Amphia Hosp, Dept Surg, Breda, Netherlands
[23] Radboud Univ Nijmegen, Dept Surg, Med Ctr, Nijmegen, Netherlands
[24] Canc Ctr Amsterdam, Amsterdam, Netherlands
关键词
CHEMOTHERAPY; PLUS; BEVACIZUMAB; STRATEGIES; OUTCOMES; SURGERY;
D O I
10.1245/s10434-023-13510-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Consensus on resectability criteria for colorectal cancer liver metastases (CRLM) is lacking, resulting in differences in therapeutic strategies. This study evaluated variability of resectability assessments and local treatment plans for patients with initially unresectable CRLM by the liver expert panel from the randomised phase III CAIRO5 study.Methods The liver panel, comprising surgeons and radiologists, evaluated resectability by predefined criteria at baseline and 2-monthly thereafter. If surgeons judged CRLM as resectable, detailed local treatment plans were provided. The panel chair determined the conclusion of resectability status and local treatment advice, and forwarded it to local surgeons.Results A total of 1149 panel evaluations of 496 patients were included. Intersurgeon disagreement was observed in 50% of evaluations and was lower at baseline than follow-up (36% vs. 60%, p < 0.001). Among surgeons in general, votes for resectable CRLM at baseline and follow-up ranged between 0-12% and 27-62%, and for permanently unresectable CRLM between 3-40% and 6-47%, respectively. Surgeons proposed different local treatment plans in 77% of patients. The most pronounced intersurgeon differences concerned the advice to proceed with hemihepatectomy versus parenchymal-preserving approaches. Eighty-four percent of patients judged by the panel as having resectable CRLM indeed received local treatment. Local surgeons followed the technical plan proposed by the panel in 40% of patients.Conclusion Considerable variability exists among expert liver surgeons in assessing resectability and local treatment planning of initially unresectable CRLM. This stresses the value of panel-baseddecisions, and the need for consensus guidelines on resectability criteria and technical approach to prevent unwarranted variability in clinical practice.
引用
收藏
页码:5376 / 5385
页数:10
相关论文
共 50 条
  • [31] Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases
    Cauchy, Francois
    Aussilhou, Beatrice
    Dokmak, Safi
    Fuks, David
    Farges, Olivier
    Faivre, Sandrine J.
    Belghiti, Jacques
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Reappraisal of the Risks and Benefits of Major Liver Resection in Patients With Initially Unresectable Colorectal Liver Metastases
    Cauchy, Francois
    Aussilhou, Beatrice
    Dokmak, Safi
    Fuks, David
    Gaujoux, Sebastien
    Farges, Olivier
    Faivre, Sandrine
    Lepille, Daniel
    Belghiti, Jacques
    ANNALS OF SURGERY, 2012, 256 (05) : 746 - 754
  • [33] Indications for conversion hepatectomy for initially unresectable colorectal cancer with liver metastasis
    Sugiyama, Masahiko
    Uehara, Hideo
    Shin, Yuki
    Shiokawa, Keiichi
    Fujimoto, Yoshiaki
    Mano, Yohei
    Komoda, Masato
    Nakashima, Yuichiro
    Sugimachi, Keishi
    Yamamoto, Manabu
    Morita, Masaru
    Toh, Yasushi
    SURGERY TODAY, 2022, 52 (04) : 633 - 642
  • [34] Photodynamic laser therapy (PDT): Treatment of unresectable liver metastases of colorectal cancer
    Engelmann, KS
    Mack, MG
    Straub, R
    Eichler, K
    Zangos, S
    Vogl, TJ
    RADIOLOGY, 2002, 225 : 447 - 447
  • [35] Stereotactic Radiotherapy: An Emerging Treatment for Unresectable Liver Metastases from Colorectal Cancer
    Mirabel, X.
    Dewas, S.
    Vautravers-Dewas, C.
    Jarraya, H.
    Lacornerie, T.
    Lartigau, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S365 - S365
  • [36] STEREOTACTIC RADIOTHERAPY: AN EMERGING TREATMENT FOR UNRESECTABLE LIVER METASTASES FROM COLORECTAL CANCER
    Mirabel, Xavier
    Dewas, Sylvain
    Vautravers-Dewas, Claire
    Jarraya, Hajer
    Lacornerie, Thomas
    Lartigau, Eric
    ANNALS OF ONCOLOGY, 2011, 22 : v66 - v66
  • [37] Indications for conversion hepatectomy for initially unresectable colorectal cancer with liver metastasis
    Masahiko Sugiyama
    Hideo Uehara
    Yuki Shin
    Keiichi Shiokawa
    Yoshiaki Fujimoto
    Yohei Mano
    Masato Komoda
    Yuichiro Nakashima
    Keishi Sugimachi
    Manabu Yamamoto
    Masaru Morita
    Yasushi Toh
    Surgery Today, 2022, 52 : 633 - 642
  • [38] Locoregional treatments of unresectable liver metastases from colorectal cancer
    Cascinu, S
    Catalano, V
    Baldelli, AM
    Scartozzi, M
    Battelli, N
    Graziano, F
    Cellerino, R
    CANCER TREATMENT REVIEWS, 1998, 24 (01) : 3 - 14
  • [39] Significance of Radiofrequency Ablation for Unresectable Colorectal Cancer With Liver Metastases
    Tago, Tomoya
    Katsumata, Kenji
    Udou, Ryutaro
    Kasahara, Kenta
    Mazaki, Junichi
    Kuwabara, Hiroshi
    Enomoto, Masanobu
    Ishizaki, Tetsuo
    Nagakawa, Yuichi
    Sugimoto, Katsutoshi
    Itoi, Takao
    Tsuchida, Akihiko
    ANTICANCER RESEARCH, 2021, 41 (11) : 5539 - 5547
  • [40] Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection
    Power, Derek G.
    Kemeny, Nancy E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 79 (03) : 251 - 264